Drugs / tirilazad

Trials 1 · a red edge is where a trial was stopped

1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00004759 Dec 1991 → Aug 2007 spinal cord injury National Institute of Neurological Disorders and Stroke (NINDS) Completed No outcome recorded

Evidence & citations 15 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as tirilazad ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004759
Known as Freedox ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as PNU 74006F ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as Tiralazad mesilate hydrate ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as Tiralazad mesylate hydrate ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as Tirilazad mesilate ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as Tirilazad mesilate anhydrous ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as TIRILAZAD MESYLATE ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as Tirilazad mesylate anhydrous ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as Tirilazad mesylate hydrate ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as Tirilazad methanesulfonate monohydrate ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as U 74006 ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Known as U-74006F ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578
Modality Small molecule CHEMBL1630578
Route Intravenous “Eight additional doses of tirilazad are administered by intravenous push.” NCT00004759